Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination

Thrombosis Research

Volumn 92, Issue 1 SUPPL. 1, 1998, Pages

  Forbes, C D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Aspirin; Dipyridamole; Drug combination; Ischaemia; Mortality; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE;

ADULT; AGED; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; STROKE; SUSTAINED RELEASE PREPARATION; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; ASPIRIN; CEREBROVASCULAR DISORDERS; DELAYED-ACTION PREPARATIONS; DIPYRIDAMOLE; DISEASE-FREE SURVIVAL; DRUG SYNERGISM; FEMALE; FIBRINOLYTIC AGENTS; HEADACHE; HEMORRHAGE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RECURRENCE;

EID: 0032531176     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00099-1     Document Type: Conference Paper

References (9)

1. Crawford N., Scrutton M.C. Biochemistry of the blood platelet. Forbes C.D., Thomas P., Tuddenham E.D.G. Haemostasis and Thrombosis. A. Bloom. 1994;89-114 Churchill Livingstone, Edinburgh.
2. Diener H., Cunha L., Forbes C.D., Sivenius J., Smets P., Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 143:1996;1-13.
3. Algra A., Van Gun J. Aspirin at any dose above 30mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry. 60:1996;197-199.
4. Muller T.H., Su C.A.P.F., Weiserberger H., Brickyl R., Nehmiz G., Eisert W.G. Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo. Br J Clin Pharmacol. 30:1990;179-186.
5. Salt Collaborative Group Swedish aspirin low dose trial (SALT) of 75 mg of aspirin as secondary prophylaxis after cerebrova scular ischaemic events. Lancet. 338:1991;1345-1349.
6. Uk-Tia Study Group, United Kingdom Transient Ischaemic Attack (UK-TIA) aspirin trial. Final results J Neurol Neurosurg Psychiatry. 54:1991;1044-1054.
7. Bertrand-Hardy J.M., Cunha L., Forbes C., Hoeven C., Hogenhuis L., Lowenthal A., Pathy J., Sivenius J., Smets P., Welbers I. European Stroke Prevention Study 2. Baseline data J Neurol Sci. 131(Suppl):1995;1-58.
8. ESPS Group The European Stroke Prevention Study (ESPS). Principal endpoints Lancet. 2:1987;1351-1354.
9. ESPS Group European Stroke Prevention Study. Stroke. 21:1990;1122-1130.